Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions.
D000818:Animals; D001667:Binding, Competitive; D002069:Butaclamol / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D006150:Guanine Nucleotides / Q000494:pharmacology*; D006892:Hydroxydopamines / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008566:Membranes / Q000378:metabolism; D009284:Naphthols / Q000378:metabolism*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism*; D013378:Substantia Nigra / Q000502:physiology*; D013764:Tetrahydronaphthalenes
D006150:Guanine Nucleotides; D006892:Hydroxydopamines; D009284:Naphthols; D011954:Receptors, Dopamine; D013764:Tetrahydronaphthalenes; C011639:ADTN; D002069:Butaclamol